MGNX Competitors & Alternatives
Compare MacroGenics Inc with similar stocks in the same industry
Biotechnology
MGNX
Main Stock$4.83
Tradestie Score
62
Market Cap
$107.45M
Revenue Growth
0.6%
Analyst Upside
+39.9%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$9.32
|
$304.12M | - | 60 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$21.79
|
$297.23M | - | 52 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$30.97
|
$293.03M | - | 58 | Compare |
|
OMER
Omeros Corporation
|
$10.51
|
$281.75M | 9.1 | 56 | Compare |
|
DBVT
DBV Technologies S.A.
|
$15.77
|
$275.54M | - | 55 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$2.06
|
$275.13M | - | 58 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$14.56
|
$269.08M | - | 56 | Compare |
|
KYTX
Kyverna Therapeutics, Inc. Common Stock
|
$8.58
|
$258.18M | - | 54 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$30.61
|
$256.54M | - | 61 | Compare |
More MGNX Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry